Most men with low-grade prostate cancer have an excellent prognosis, with a five-year survival rate of more than 99%. But ...

An expert on prostate cancer gives a brief overview of castrate-resistant prostate cancer. This is a synopsis of an Educated Patient Sound Bites series featuring Alicia Morgans, MD, MPH, of ...

Prostate cancer starts in the prostate, a small gland located below the bladder that is responsible for secreting one of the components of semen. Prostate cells may grow out of control and become ...

Drs. Pallabi Mustafi and Ruben Raychaudhuri at Fred Hutch Cancer Center recently received Young Investigator Awards from the ...

Most prostate cancers rely on male sex hormones, known as androgens, to grow. As a result, standard treatment focuses on ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients.

This trial is looking at whether doctors can use PSMA PET-CT scans to guide treatment for people who have high risk prostate cancer.

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients.

Doctors do not typically use a cystoscopy to detect or diagnose prostate cancer, but it may reveal abnormalities in the prostate or signs of cancer in the bladder and other areas of the urinary tract.

orgovyx (relugolix) is a medicine used to treat advanced prostate cancer in adults. Advanced prostate cancer means that the cancer has spread outside of the prostate. Advanced cancers have often come ...

Note: While research on alcohol is evolving, the Centers for Disease Control and Prevention says drinking less or not at all is better for your health. Alcohol is part of many people’s social lives, ...